Disparities in the management and outcome of cervical cancer in the United States according to health insurance status

Gynecologic Oncology

Volumn 141, Issue 3, 2016, Pages 516-523

  Churilla, Thomas ^a   Egleston, Brian ^a   Dong, Yanqun ^a   Shaikh, Talha ^a   Murphy, Colin ^a   Mantia Smaldone, Gina ^a   Chu, Christina ^a   Rubin, Stephen ^a   Anderson, Penny ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRACHYTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CAUSE SPECIFIC SURVIVAL; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; GROUPS BY AGE; HEALTH CARE DISPARITY; HEALTH INSURANCE; HUMAN; INVASIVE CARCINOMA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MEDICAID; MEDICALLY UNINSURED; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; SOCIOECONOMICS; UNITED STATES; UTERINE CERVIX CANCER; ADOLESCENT; CANCER REGISTRY; ECONOMICS; EPIDEMIOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

ADOLESCENT; ADULT; FEMALE; HEALTHCARE DISPARITIES; HUMANS; INSURANCE, HEALTH; MEDICAID; MIDDLE AGED; NEOPLASM STAGING; SEER PROGRAM; TREATMENT OUTCOME; UNITED STATES; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84961842661     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2016.03.025     Document Type: Article

References (29)

1. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin, KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.
2. Whitlock, E.P., et al. Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the U.S. Preventive Services Task Force. Ann. Intern. Med. 155:687–697 (2011), W214–W215.
3. Peirson, L., Fitzpatrick-Lewis, D., Ciliska, D., Warren, R., Screening for cervical cancer: a systematic review and meta-analysis. Syst. Rev., 2, 2013, 35.
4. Simard, E.P., Naishadham, D., Saslow, D., Jemal, A., Age-specific trends in black-white disparities in cervical cancer incidence in the United States: 1975-2009. Gynecol. Oncol. 127 (2012), 611–615.
5. Simard, E.P., Fedewa, S., Ma, J., Siegel, R., Jemal, A., Widening socioeconomic disparities in cervical cancer mortality among women in 26 states, 1993–2007. Cancer 118 (2012), 5110–5116.
6. Sharma, C., et al. Patterns of care and treatment outcomes for elderly women with cervical cancer. Cancer 118 (2012), 3618–3626.
7. Brookfield, K.F., Cheung, M.C., Lucci, J., Fleming, L.E., Koniaris, L.G., Disparities in survival among women with invasive cervical cancer: a problem of access to care. Cancer 115 (2009), 166–178.
8. Fedewa, S.A., et al. Association of insurance status and age with cervical cancer stage at diagnosis: National Cancer Database, 2000–2007. Am. J. Public Health 102 (2012), 1782–1790.
9. Walker, G.V., et al. Disparities in stage at diagnosis, treatment, and survival in nonelderly adult patients with cancer according to insurance status. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 32 (2014), 3118–3125.
10. ASPA, Key Features of the Affordable Care Act By Year. 2013 (Available at: http://www.hhs.gov/healthcare/facts/timeline/timeline-text.html. (Accessed: 13th October 2014)).
11. Examining access to care in Medicaid and CHIP. In: Medicaid and CHIP Payment and Access Commission. Report to the Congress on Medicaid and CHIP. March 2011: 124-54 (http://www.macpac.gov/reports).
12. Rosenbaum, S., Medicaid payments and access to care. N. Engl. J. Med. 371 (2014), 2345–2347.
13. Edge, S.B., AJCC Cancer Staging Handbook: From the AJCC Cancer Staging Manual. 2002, Springer.
14. Jagsi, R., et al. Underascertainment of radiotherapy receipt in surveillance, epidemiology, and end results registry data. Cancer 118 (2012), 333–341.
15. Walker, G.V., et al. Muddy water? Variation in reporting receipt of breast cancer radiation therapy by population-based tumor registries. Int. J. Radiat. Oncol. Biol. Phys. 86 (2013), 686–693.
16. Levinson, K.L., Bristow, R.E., Donohue, P.K., Kanarek, N.F., Trimble, C.L., Impact of payer status on treatment of cervical cancer at a tertiary referral center. Gynecol. Oncol. 122 (2011), 324–327.
17. Rosenbaum, S., The ACA: implications for the accessibility and quality of breast and cervical cancer prevention and treatment services. Public Health Rep. 127 (2012), 340–344.
18. Felland, L.E., Lechner, A., Sommers, A., Improving Access to Specialty Care for Medicaid patients: Policy Issues and Options. 2013, The Commonwealth Fund, New York (http://www.commonwealthfund.org/~/media/files/publications/fund-report/2013/jun/1691_felland_improving_access_specialty_care_medicaid_v2.pdf).
19. Berk, M.L., Schur, C.L., Access to care: how much difference does Medicaid make?. Health Aff. Proj. Hope 17 (1998), 169–180.
20. Breen, N., Wagener, D.K., Brown, M.L., Davis, W.W., Ballard-Barbash, R., Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J. Natl. Cancer Inst. 93 (2001), 1704–1713.
21. Swan, J., et al. Data and trends in cancer screening in the United States: results from the 2005 National Health Interview Survey. Cancer 116 (2010), 4872–4881.
22. Hsia, J., et al. The importance of health insurance as a determinant of cancer screening: evidence from the Women's Health Initiative. Prev. Med. 31 (2000), 261–270.
23. Potosky, A.L., Breen, N., Graubard, B.I., Parsons, P.E., The association between health care coverage and the use of cancer screening tests. Results from the 1992 National Health Interview Survey. Med. Care 36 (1998), 257–270.
24. Nash, D., Chan, C., Horowitz, D., Vlahov, D., Barriers and missed opportunities in breast and cervical cancer screening among women aged 50 and over, New York City, 2002. J. Women's Health 2002:16 (2007), 46–56.
25. National Comprehensive Cancer Network. Cervical Cancer (Version 2.2015). http://www.nccn.org/professionals/physician_gls/pdf/cervical.pdf. Accessed 1/30/2015.
26. Han, K., Milosevic, M., Fyles, A., Pintilie, M., Viswanathan, A.N., Trends in the utilization of brachytherapy in cervical cancer in the United States. Int. J. Radiat. Oncol. Biol. Phys. 87 (2013), 111–119.
27. Grant, S.R., et al. Impact of insurance status on radiation treatment modality selection among potential candidates for prostate, breast, or gynecologic brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 93 (2015), 968–975.
28. Public Law 111 - 148 - Patient Protection and Affordable Care Act. Available at: http://www.gpo.gov/fdsys/pkg/PLAW-111publ148/content-detail.html. (Accessed: 5th November 2015).
29. Smith, G.L., Eifel, P.J., Trends in the utilization of brachytherapy in cervical cancer in the United States. In regard to Han et al. Int. J. Radiat. Oncol. Biol. Phys. 88 (2014), 459–460.